From Surf Wiki (app.surf) — the open knowledge base
Tilmicosin
Tilmicosin is a macrolide antibiotic. It is distributed under the brand name Micotil. It is used in veterinary medicine for the treatment of bovine respiratory disease and enzootic pneumonia caused by Mannheimia (Pasteurella) haemolytica in sheep. In humans, Tilmicosin causes fatal cardiotoxic effects at amounts greater than 1 milliliter when injected, something most commonly seen in veterinary personnel and farmers. Tilmicosin, like most macrolides, is a Calcium channel blocker. However, because Micotil is formulated for animals like cows, it has exceptionally more potent Ca channel blocking effects in humans with a dose of .5 mL causing significant poisoning and a dose of 5-6 ml being lethal.
References
References
- [http://www.fao.org/docrep/W4601E/w4601e0e.htm Tilmicosin], [[United Nations Food and Agriculture Organization]]
- (3 August 2022). "Health product highlights 2021: Annexes of products approved in 2021".
- [https://web.archive.org/web/20090710082244/http://www.fda.gov/downloads/AnimalVeterinary/Products/ApprovedAnimalDrugProducts/FOIADrugSummaries/ucm115928.pdf Micotil 300 New Animal Drug Application], [[United States Food and Drug Administration]]
- [https://www.canada.ca/en/health-canada/services/drugs-health-products/veterinary-drugs/adverse-drug-reactions-adrs/micotil-tilmicosin.html Micotil (tilmicosin) - Adverse Drug Reactions - Veterinary Drugs], [[Health Products and Food Branch. Veterinary Drugs Directorate]]
- (July 2020). "Toxicology Rounds: An Animal Antibiotic Lethal to Humans in Tiny Doses". Emergency Medicine News.
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Tilmicosin — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report